Patents by Inventor Ekaterina Bassett

Ekaterina Bassett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9951389
    Abstract: Provided herein are methods for identifying individuals diagnosed with a cell proliferative disorder that will benefit from treatment with a telomerase inhibitor compound. Also provided herein are methods for treating these individuals with telomerase inhibitor compounds.
    Type: Grant
    Filed: October 30, 2015
    Date of Patent: April 24, 2018
    Assignee: Geron Corporation
    Inventors: Ekaterina Bassett, Bart Burington, Hui Wang, Kevin Eng
  • Publication number: 20160177403
    Abstract: Provided herein are methods for identifying individuals diagnosed with a cell proliferative disorder that will benefit from treatment with a telomerase inhibitor compound. Also provided herein are methods for treating these individuals with telomerase inhibitor compounds.
    Type: Application
    Filed: October 30, 2015
    Publication date: June 23, 2016
    Inventors: Ekaterina BASSETT, Bart BURINGTON, Hui WANG, Kevin ENG
  • Publication number: 20150344963
    Abstract: Provided herein are methods for identifying individuals diagnosed with a cell proliferative disorder that will benefit from treatment with a telomerase inhibitor compound. Also provided herein are methods for treating these individuals with telomerase inhibitor compounds. The methods comprise identifying individuals who will benefit from said treatment based on the average relative length of telomeres in cancer cells from said individuals.
    Type: Application
    Filed: November 27, 2013
    Publication date: December 3, 2015
    Inventors: Ekaterina BASSETT, Bart BURINGTON, Hui WANG, Kevin ENG
  • Patent number: 9200327
    Abstract: Provided herein are methods for identifying individuals diagnosed with a cell proliferative disorder that will benefit from treatment with a telomerase inhibitor compound. Also provided herein are methods for treating these individuals with telomerase inhibitor compounds.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: December 1, 2015
    Assignee: Geron Corporation
    Inventors: Ekaterina Bassett, Bart Burington, Hui Wang, Kevin Eng
  • Publication number: 20140155465
    Abstract: Provided herein are methods for identifying individuals diagnosed with a cell proliferative disorder that will benefit from treatment with a telomerase inhibitor compound. Also provided herein are methods for treating these individuals with telomerase inhibitor compounds.
    Type: Application
    Filed: March 13, 2013
    Publication date: June 5, 2014
    Inventors: Ekaterina BASSETT, Bart Burington, Hui Wang, Kevin Eng
  • Publication number: 20090142770
    Abstract: The invention is directed to methods for determining the efficacy of treatment with telomerase modulators in mammals by the analysis of the level of telomerase reverse transcriptase activity in mammalian hair follicle cells.
    Type: Application
    Filed: December 3, 2008
    Publication date: June 4, 2009
    Applicant: Geron Corporation
    Inventors: Ning F. Go, Calvin B. Harley, Ekaterina Bassett, Zhu Zhen Pirot